These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 35980860)

  • 1. Systemic Barriers in Receiving Electronically Prescribed Glaucoma Medications.
    Oke I; Badami A; Kosteva KL; Wu K; Desai MA
    J Glaucoma; 2022 Oct; 31(10):812-815. PubMed ID: 35980860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glaucoma severity and medication adherence in a county hospital population.
    Ung C; Zhang E; Alfaro T; Murakami Y; Zhang M; Seider MI; Lin SC; Singh K
    Ophthalmology; 2013 Jun; 120(6):1150-7. PubMed ID: 23453512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Medication Adherence Assessment Tools to Identify Glaucoma Medication Nonadherence.
    Cho J; Niziol LM; Lee PP; Heisler M; Resnicow K; Musch DC; Newman-Casey PA
    Ophthalmol Glaucoma; 2022; 5(2):137-145. PubMed ID: 34358735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accuracy of Patient-reported Adherence to Glaucoma Medications on a Visual Analog Scale Compared With Electronic Monitors.
    Sayner R; Carpenter DM; Blalock SJ; Robin AL; Muir KW; Hartnett ME; Giangiacomo AL; Tudor G; Sleath B
    Clin Ther; 2015 Sep; 37(9):1975-85. PubMed ID: 26164785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Efficacy of the After-visit Summary in Medication Recall Among Glaucoma Patients.
    Hirabayashi KJ; Pomerantz M; Radell JE; Chadha N; Thomas S; Serle JB
    J Glaucoma; 2020 Jul; 29(7):529-535. PubMed ID: 32332333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors Affecting Adherence to Topical Glaucoma Therapy: A Quantitative and Qualitative Pilot Study Analysis in Sydney, Australia.
    Spencer SKR; Shulruf B; McPherson ZE; Zhang H; Lee MB; Francis IC; Bank A; Coroneo MT; Agar A
    Ophthalmol Glaucoma; 2019; 2(2):86-93. PubMed ID: 32672609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Readability of prescription labels and medication recall in a population of tertiary referral glaucoma patients.
    O'Hare F; Jeganathan VS; Rokahr CG; Rogers SL; Crowston JG
    Clin Exp Ophthalmol; 2009 Dec; 37(9):849-54. PubMed ID: 20092593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physician assessments of medication adherence and decisions to intensify medications for patients with uncontrolled blood pressure: still no better than a coin toss.
    Meddings J; Kerr EA; Heisler M; Hofer TP
    BMC Health Serv Res; 2012 Aug; 12():270. PubMed ID: 22909303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interventions improve poor adherence with once daily glaucoma medications in electronically monitored patients.
    Okeke CO; Quigley HA; Jampel HD; Ying GS; Plyler RJ; Jiang Y; Friedman DS
    Ophthalmology; 2009 Dec; 116(12):2286-93. PubMed ID: 19815286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electronic monitoring to assess adherence with once-daily glaucoma medications and risk factors for nonadherence: the automated dosing reminder study.
    Boland MV; Chang DS; Frazier T; Plyler R; Friedman DS
    JAMA Ophthalmol; 2014 Jul; 132(7):838-44. PubMed ID: 24830878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measurement of persistence and adherence to regimens of IOP-lowering glaucoma medications using pharmacy claims data.
    Wilensky J; Fiscella RG; Carlson AM; Morris LS; Walt J
    Am J Ophthalmol; 2006 Jan; 141(1 Suppl):S28-33. PubMed ID: 16389058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantifying Glaucoma Medication Adherence: The Relationship Between Self-Report, Electronic Monitoring, and Pharmacy Refill.
    Kumar JB; Bosworth HB; Sleath B; Woolson S; Olsen M; Danus S; Muir KW
    J Ocul Pharmacol Ther; 2016; 32(6):346-54. PubMed ID: 27058842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heritable Risk and Protective Genetic Components of Glaucoma Medication Non-Adherence.
    Barr JL; Feehan M; Tak C; Owen LA; Finley RC; Cromwell PA; Lillvis JH; Hicks PM; Au E; Farkas MH; Weiner A; Reynolds AL; Sieminski SF; Sherva RM; Munger MA; Brilliant MH; DeAngelis MM
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adherence to topical glaucoma medications and associated factors in Gondar University Hospital Tertiary Eye Care Center, northwest Ethiopia.
    Anbesse DH; Yibekal BT; Assefa NL
    Eur J Ophthalmol; 2019 Mar; 29(2):189-195. PubMed ID: 29747522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Facilitators and Barriers to Glaucoma Medication Adherence.
    Gatwood J; Brooks C; Meacham R; Abou-Rahma J; Cernasev A; Brown E; Kuchtey RW
    J Glaucoma; 2022 Jan; 31(1):31-36. PubMed ID: 34772874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Most Common Barriers to Glaucoma Medication Adherence: A Cross-Sectional Survey.
    Newman-Casey PA; Robin AL; Blachley T; Farris K; Heisler M; Resnicow K; Lee PP
    Ophthalmology; 2015 Jul; 122(7):1308-16. PubMed ID: 25912144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A study of the association between patterns of eye drop prescription and medication usage in glaucoma subjects.
    Kawai-Tsuboi N; Kawai M; Minami Y; Yoshida A
    J Glaucoma; 2015 Mar; 24(3):202-6. PubMed ID: 23807351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting Adherence With the Glaucoma Treatment Compliance Assessment Tool.
    Sanchez FG; Mansberger SL; Newman-Casey PA
    J Glaucoma; 2020 Nov; 29(11):1017-1024. PubMed ID: 32740508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of patient inexperience in medication discontinuation: a retrospective analysis of medication nonpersistence in seven chronic illnesses.
    Vanelli M; Pedan A; Liu N; Hoar J; Messier D; Kiarsis K
    Clin Ther; 2009 Nov; 31(11):2628-52. PubMed ID: 20110007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between dispensing channel and medication adherence among medicare beneficiaries taking medications to treat diabetes, high blood pressure, or high blood cholesterol.
    Iyengar RN; Balagere DS; Henderson RR; LeFrancois AL; Rabbitt RM; Frazee SG
    J Manag Care Spec Pharm; 2014 Aug; 20(8):851-61. PubMed ID: 25062079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.